A new study reveals head impact, not concussion, triggers CTE. The discovery could help with early detection and treatments for the neurodegenerative disorder.
The P522R gene variant increases expression levels of several microglia genes which are reduced in people with Alzheimer's disease.
Changes in gene expression help researchers identify ALS associated pathways and establish the key drivers of motor neuron degeneration in the disease.
A molecular process caused by the TREM2 gene mutation in the brain's microglia increases the risk of Alzheimer's disease, a new study reports.
Researchers report microglia may actually protect the brain against Alzheimer's disease by containing the spread of amyloid plaques.
Testing for specific inflammatory proteins in cerebrospinal fluid can help doctors to diagnose the early onset of Alzheimer's disease and track the progression of the disease in patients.
DHA treatment reduced the size of the damaged brain area and initiated a repair mechanism in animal models of stroke. DHA affected the levels of MANF and TREM2, two proteins critical for communication between brain cells.
Researchers uncover a second rare genetic mutation which increases the risk of developing Alzheimer's disease later in life.
According to a new study, triggering TREM2 could help slow the progression of some neurodegenerative diseases.
Stimulating microglial cells could delay the onset of some neurodegenerative diseases, researchers report.
A new study investigates how genetics risk factors for Alzheimer's could influence a key immune cell.
Rapamycin, a drug approved for the treatment of cancer and transplant patients increases amyloid-beta protein plaques in the brains of mice.
